4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001209191-21-020478
Options or other derivatives
- CEO acquired 225,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
PIMSTONE SIMON N. · CEO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-12 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +225,000 | 225,000 | D |
Loading xslF345X03/doc4.xml…